NEW STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION OF CAPECITABINE AND DOCETAXEL IN BULK AND PHARMACEUTICAL DOSAGE FORM BY USING RP-HPLC

Authors

  • NEEHARIKA TIRUMALASETTY Department of Chemistry, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, Andhra Pradesh 522510, India
  • RAMCHANDRAN D. Department of Chemistry, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, Andhra Pradesh 522510, India

DOI:

https://doi.org/10.22159/ijap.2021v13i542488

Keywords:

Capecitabine, Docetaxel, RP-HPLC, Development, Validation

Abstract

Objective: The current investigation was pointed at developing and progressively validating novel, simple, responsive and stable RP-HPLC method for the measurement of active pharmaceutical ingredients of Capecitabine and Docetaxel.

Methods: A simple, selective, validated and well-defined stability that shows gradient RP-HPLC methodology for the quantitative determination of Capecitabine and Docetaxel. The chromatographic strategy utilized Inertsil ODS column of dimensions 250x4.6 mm, 5 micron, using isocratic elution with a mobile phase of acetonitrile and water (50:50). A flow rate of 1 ml/min and a detector wavelength of 220 nm utilizing the PDA detector were given in the instrumental settings. Using the impurity-spiked solution, the chromatographic approach was streamlined. Validation of the proposed method was carried out according to an international conference on harmonization (ICH) guidelines.

Results: LOD and LOQ for the two active ingredients and their impurities were established with respect to test concentration. The calibration charts plotted were linear with a regression coefficient of R2>0.999, means the linearity was within the limit. Recovery, specificity, linearity, accuracy, robustness, ruggedness were determined as a part of method validation and the results were found to be within the acceptable range.

Conclusion: The proposed method to be fast, simple, feasible and affordable in assay condition. During stability tests, it can be used for routine analysis of production samples and to verify the quality of drug samples during stability studies.

Downloads

Download data is not yet available.

References

Roness H, Kalich Philosoph L, Meirow D. Prevention of chemotherapy induced ovarian damage possible roles for hormonal and non hormonal attenuating agents. Hum Reprod Update 2014;20:759–74.

Savage L. Chemotherapy induced pain puzzles scientists. J National Cancer Institute 2007;99:1070–1.

Eliassen AH, Hankinson SE, Rosner B, Holmes MD, Willett WC. Physical activity and risk of breast cancer among postmenopausal women. Arch Intern Med 2010;170:1758–64.

Kaiser J. Cancer cholesterol forges link between obesity and breast cancer. Science 2013;342:1028.

Paterson HM, McCole D, Auld CD. Impact of open-access endoscopy on detection of early oesophageal and gastric cancer 1994–2003. Population based study. Endoscopy 2006;38:503–7.

Yau, Tung On. Precision treatment in colorectal cancer. Now and the future. JGH Open 2019;3:361–9.

Tytgat GN. Hyoscine butylbromide a review of its use in the treatment of abdominal cramping and pain. Drugs 2007;67:1343–57.

Hunt, Beverley J. Bleeding and coagulopathies in critical care. N Engl J Med 2014;370:847–59.

May JR, Dolen WK. Management of allergic rhinitis. A review for the community pharmacist. Clin Ther 2017;39:2410–9.

Simpson S, Rutland P, Rutland CS. Genomic insights into cardiomyopathies. A comparative cross species review. Vet Sci 2017;4:19.

Moore EM, Bellomo R, Nichol AD. The meaning of acute kidney injury and its relevance to intensive care and anaesthesia. Anaesth Intensive Care 2012;40:929–48.

Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, et al. Clinical pharmacogenetics implementation consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther 2013;94:640–5.

Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol 2013;19:5598–606.

Chow, Laura QM. Head and neck cancer. N Engl J Med 2020;382:60–72.

Specenier P, Vermorken JB. Advances in the systemic treatment of head and neck cancers. Curr Opinion Oncol 2010;22:200–5.

Norris JM, Simpson BS, Freeman A, Kirkham A, Whitaker HC, Emberton M. Conspicuity of prostate cancer on multiparametric magnetic resonance imaging. A cross disciplinary translational hypothesis. FASEB J 2020;34:14150–9.

Nasser, Nicola J, Gorenberg, Miguel, Agbarya, Abed. First line immunotherapy for non small cell lung cancer. Pharmaceuticals 2020;13:373.

Wang HJ, Gao B, Zakhari S, Nagy LE. Inflammation in alcoholic liver disease. Annu Rev Nutr 2012;32:343–68.

Chaaban S, Brouhard GJ. A microtubule bestiary structural diversity in tubulin polymers. Mol Biol Cell 2017;28:2924–31.

Lyseng Williamson KA, Fenton C. Docetaxel a review of its use in metastatic breast cancer. Drugs 2005;65:2513–31.

Shelley M, Harrison C, Coles B, Staffurth J, Wilt TJ, Mason MD. Chemotherapy for hormone refractory prostate cancer. Cochrane Database Syst Rev 2006;CD005247.

Subrahmanyam Talari, Anuradha V, Komala Sai Prathyusha A. New validated RP-HPLC method for cisplatin and topotecan in API and vaccine form and its stress studies. Int J Res Pharm Sci 2021;12:808-14.

Syed Rafi, Kantipudi Rambabu. Stability indicating validated HPLC method for the determination of aceclofenac and misoprostol in bulk and pharmaceutical formulation. Int J Res Pharm Sci 2020;11:7848-53.

Bhavani P, Prasada Rao K, Mohan S. Novel validated reversed phase high performance liquid chromatography method for determination of glucosamine, diacerein, and methyl sulfonyl methane in micro sample rat plasma and its application to pharmacokinetic and dissolution studies. Asian J Pharm Clin Res 2020;13:50-63.

Shivani CP, Maheshwari DG. Development and validation of UV spectrometric and HPLC method for estimation of escitalopram oxalate and flupentixol dihydrochloride in combined dosage form. Asian J Pharm Technol Innovations 2016;4:59-70.

Asha Eluru, Surendra Babu K. A study of method development, validation and forced degradation for simultaneous quantification of povidone iodine and ornidazole in bulk and pharmaceutical dosage form by using RP-HPLC. IJPSR 2021;12:1217-22.

Swati K, Abhishek P, Sushank S, Bothiraja C, Atmaram P. High-performance liquid chromatography for the simultaneous estimation of cefoperazone and sulbactam in rat plasma and its importance in therapeutic drug monitoring. Int J Pharm Pharm Sci 2020;12:92-7.

Vijayakumari M, Balasekhar Reddy Ch. Stability indicating validated hplc method for the determination of zanubrutinib in bulk and pharmaceutical dosage form. Asian J Pharm Clin Res 2020;13:159-62.

Abdul Raziq, Syed Umer Jan. Relative comparison of stability and degradation of methylcobalamine tablets of different brands at different storage settings. Int J Appl Pharm 2021;13:171-5.

Rajakumari R, Sreenivasa Rao S. Stress degradation studies and development of a validated RP-HPLC method for determination of tiagabine in presence of its degradation products. Int J Pharm Pharm Sci 2016;8:230-6.

Charu Pandya P, Sadhana Rajput J. Development and validation of stability indicating method RP-HPLC method of acotiamide. Int J Pharm Pharm Sci 2018;10:1-8.

Birva Athavia A, Zarna Dedania R. Stability indicating HPLC method for determination of vilazodone hydrochloride. Int J Curr Pharm Res 2017;9:123-9.

Published

07-09-2021

How to Cite

TIRUMALASETTY, N., & D., R. (2021). NEW STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION OF CAPECITABINE AND DOCETAXEL IN BULK AND PHARMACEUTICAL DOSAGE FORM BY USING RP-HPLC. International Journal of Applied Pharmaceutics, 13(5), 177–182. https://doi.org/10.22159/ijap.2021v13i542488

Issue

Section

Original Article(s)